← Insider buys
KPTI

Karyopharm Therapeutics Inc. · Healthcare

CEO Michael Kauffman sold $240K of Karyopharm Therapeutics Inc.

Sold$240,000
$12.00Price
20,000Shares
−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Mon, Sep 16. Filed Tue, Sep 17, 12:56 PM ET, during the session. Not investment advice.